Aimin Jiang

1.3k total citations · 2 hit papers
63 papers, 709 citations indexed

About

Aimin Jiang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Aimin Jiang has authored 63 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Aimin Jiang's work include Renal cell carcinoma treatment (17 papers), Ferroptosis and cancer prognosis (15 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Aimin Jiang is often cited by papers focused on Renal cell carcinoma treatment (17 papers), Ferroptosis and cancer prognosis (15 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Aimin Jiang collaborates with scholars based in China, Hong Kong and Macao. Aimin Jiang's co-authors include Peng Luo, Anqi Lin, Quan Cheng, Jian Zhang, Linhui Wang, Zaoqu Liu, Le Qu, Yifeng Bai, Xinxin Gan and Anbang Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Scientific Reports.

In The Last Decade

Aimin Jiang

53 papers receiving 696 citations

Hit Papers

CTLs heterogeneity and plasticity: implications for cance... 2024 2026 2025 2024 2025 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CTLs heterogeneity and plasticity: implications for cancer immunotherapy
    2024 62 citations Anqi Lin, Aimin Jiang et al. profile →
  2. From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
    2025 34 citations Anqi Lin, Aimin Jiang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aimin Jiang China 15 348 218 218 157 156 63 709
Gonzalo Rodríguez‐Berriguete Spain 17 368 1.1× 184 0.8× 158 0.7× 81 0.5× 167 1.1× 22 623
Yu Bai China 16 451 1.3× 159 0.7× 228 1.0× 177 1.1× 253 1.6× 49 848
Kamila Wojas‐Krawczyk Poland 15 220 0.6× 314 1.4× 384 1.8× 144 0.9× 125 0.8× 77 751
Haitao Chen China 16 445 1.3× 210 1.0× 357 1.6× 178 1.1× 190 1.2× 56 969
Jianya Zhou China 16 364 1.0× 376 1.7× 391 1.8× 90 0.6× 189 1.2× 74 898
Huaxin Zhou China 16 397 1.1× 104 0.5× 150 0.7× 166 1.1× 151 1.0× 42 756
Pingping Dong China 13 323 0.9× 114 0.5× 231 1.1× 273 1.7× 146 0.9× 39 740
Fanming Kong China 12 226 0.6× 113 0.5× 180 0.8× 87 0.6× 96 0.6× 61 515

Countries citing papers authored by Aimin Jiang

Since Specialization
Citations

This map shows the geographic impact of Aimin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimin Jiang more than expected).

Fields of papers citing papers by Aimin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimin Jiang. The network helps show where Aimin Jiang may publish in the future.

Co-authorship network of co-authors of Aimin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Aimin Jiang. A scholar is included among the top collaborators of Aimin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimin Jiang. Aimin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Anqi, Aimin Jiang, Li Chen, et al.. (2025). Large language models in clinical trials: applications, technical advances, and future directions. BMC Medicine. 23(1). 563–563. 1 indexed citations
2.
Gao, Zhifei, Aimin Jiang, Zizhuo Li, et al.. (2025). Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development. SHILAP Revista de lepidopterología. 1(1). 32–61. 10 indexed citations
3.
Jiang, Tong, Aimin Jiang, Qi Chang, et al.. (2025). Performance analysis of large language models in multi-disease detection from chest computed tomography reports: a comparative study. International Journal of Surgery. 111(8). 5071–5087. 1 indexed citations
4.
Lin, Anqi, Aimin Jiang, Xufeng Huang, et al.. (2025). The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events. SHILAP Revista de lepidopterología. 1(3). 322–358. 2 indexed citations
5.
Zhang, Haixiang, et al.. (2025). Deciphering the molecular heterogeneity of soft tissue sarcoma by integrating multiomics and single cell sequence. The International Journal of Biochemistry & Cell Biology. 185. 106801–106801.
6.
Jiang, Aimin, et al.. (2025). Re: HIF Regulates Multiple Translated Endogenous Retroviruses: Implications for Cancer Immunotherapy. European Urology. 88(4). 419–420.
7.
Jiang, Aimin, Hong Yang, Kexin Li, et al.. (2025). DrugSurvPlot: A Novel Web-Based Platform Harnessing Drug Sensitivity Scores as Molecular Biomarkers for Pan-Cancer Survival Prognosis. Current Gene Therapy. 26(1). 187–202.
8.
Hao, Yanhong, et al.. (2025). Multiomics Analysis of Exportin Family Reveals XPO1 as a Novel Target for Clear Cell Renal Cell Carcinoma. International Journal of Genomics. 2025(1). 3645641–3645641.
9.
Jiang, Aimin, Wenqiang Liu, Qiwei Yang, et al.. (2024). TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study. SHILAP Revista de lepidopterología. 4(4). 382–394. 3 indexed citations
10.
Zuo, Qiao, Aimin Jiang, Nan Lv, et al.. (2024). Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics. Brain. 147(8). 2817–2825. 6 indexed citations
11.
12.
Qi, Lin, Bicheng Ye, Anbang Wang, et al.. (2024). MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level. Cancer Biology & Therapy. 25(1). 2345977–2345977.
13.
Liu, Ying, Meng Zhu, Chengcheng Hu, et al.. (2024). Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers. Journal of Cellular and Molecular Medicine. 28(16). e70034–e70034. 3 indexed citations
14.
Ye, Bicheng, et al.. (2024). Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI‐driven stemness‐related gene signature. Journal of Cellular and Molecular Medicine. 28(14). e18564–e18564. 10 indexed citations
15.
Jiang, Aimin, Zi‐jun Xu, Xiao Fang, et al.. (2023). RNA modification pattern‐based subtypes reveal heterogenous clinical outcomes and tumor immunity of clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 2(1). 7 indexed citations
16.
Wang, Zheng, Yunyun Wang, Jiachao Xiong, et al.. (2023). Causal effects of hypertension on risk of erectile dysfunction: A two-sample Mendelian randomization study. Frontiers in Cardiovascular Medicine. 10. 1121340–1121340. 7 indexed citations
17.
Jiang, Aimin, Le Qu, Bing Liu, Anbang Wang, & Linhui Wang. (2023). Reconsidering the role of receptors for SARS‐CoV‐2 in clear cell renal cell carcinoma: Friends or foes. SHILAP Revista de lepidopterología. 2(1).
18.
Meng, Jialin, Aimin Jiang, Xiaofan Lu, et al.. (2023). Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. SHILAP Revista de lepidopterología. 2(4). e147–e147. 21 indexed citations
19.
Jiang, Aimin, Chen Cai, Wenqiang Liu, et al.. (2023). Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. Oxidative Medicine and Cellular Longevity. 2023. 1–31. 1 indexed citations
20.
Jiang, Aimin, Ye Zhou, Wenliang Gong, et al.. (2022). CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. Oxidative Medicine and Cellular Longevity. 2022(1). 5910575–5910575. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gonzalo Rodríguez‐Berriguete Breakdown of academic impact, for papers by Yu Bai Breakdown of academic impact, for papers by Kamila Wojas‐Krawczyk Breakdown of academic impact, for papers by Haitao Chen Breakdown of academic impact, for papers by Jianya Zhou Breakdown of academic impact, for papers by Huaxin Zhou Breakdown of academic impact, for papers by Pingping Dong Breakdown of academic impact, for papers by Fanming Kong
Rankless by CCL
2026